Lopes R.D.
771
Coauthors
13
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2013 | 2 |
| 2018 | 1 |
| 2019 | 6 |
| 2021 | 1 |
| 2022 | 3 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Enfermedad cardiovascular | 9 |
| Medicina interna | 9 |
| Ensayo clínico | 4 |
| Salud pública | 2 |
| Medicamento | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 11 |
| Medicina y salud | 9 |
| Farmacología y terapéutica | 6 |
| Problemas sociales y servicios a grupos | 4 |
| Fisiología humana | 3 |
| Ginecología, obstetricia, pediatría, geriatría | 1 |
| Derecho | 1 |
| Salud y seguridad personal | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 13 |
| Google Scholar | 5 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Bhatt D.L. | 7 |
| Goodman S.G. | 7 |
| PATRICIO LOPEZ -JARAMILLO | 7 |
| Jukema J.W. | 7 |
| Harrington R.A. | 6 |
| Szarek M. | 6 |
| Bittner V.A. | 6 |
| Zeiher A.M. | 6 |
| DIaz R. | 6 |
| Octavio Marques Pontes-Neto | 6 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Rationale and design for a cluster randomized quality-improvement trial to increase the uptake of evidence-based therapies for patients at high cardiovascular risk: The BRIDGE-Cardiovascular Prevention trial
ArticleAbstract: Background: Translating evidence into clinical practice in the management of high cardiovascular risPalabras claves:Autores:Amodeo C., Berwanger O., Brandão Da Silva N., Campos V.B., Damiani L.P., de Melo Barros P.G., Fonseca F.H., Guimarães H.P., Izar M.C., Lopes R.D., Machline-Carrion M.J., Octavio Marques Pontes-Neto, Piegas L.S., Sampaio B., Soares R.M., Stein A.T., Yamashita J.Fuentes:scopusRisk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes
ArticleAbstract: Background: The 2018 US cholesterol management guidelines recommend additional lipid-lowering therapPalabras claves:acute coronary syndrome, alirocumab, dyslipidemias, GUIDELINEAutores:Baccara-Dinet M.T., Bhatt D.L., Bittner V.A., DIaz R., Goodman S.G., Harrington R.A., Jukema J.W., Li Q.H., Lopes R.D., Louie M.J., Moriarty P.M., PATRICIO LOPEZ -JARAMILLO, Roe M.T., Schwartz G.G., Steg P.G., Szarek M., Vogel R., White H.D., Zeiher A.M.Fuentes:googlescopusAn international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE Trial
ArticleAbstract: Background: Translating evidence into clinical practice in the management of acute ischemic stroke (Palabras claves:Autores:Bahit C., Berwanger O., Bettger J.P., Bueno P.R.T., Cavalcanti A.B., da Silva B.G.P., Damiani L.P., De Andrade Jesuíno I., De Salles A., Freitas G.R.d., Gorgulho A., Guimarães H.P., Lopes R.D., Machline-Carrion M.J., Málaga G., Martins S.O., Normilio-Silva K., Octavio Marques Pontes-Neto, Peterson E.D., Santos J.Y., Santucci E.V., Xian Y., Zétola V.H.F.Fuentes:scopusEffect of a Quality Improvement Intervention on Adherence to Therapies for Patients with Acute Ischemic Stroke and Transient Ischemic Attack: A Cluster Randomized Clinical Trial
ArticleAbstract: Importance: Translating evidence into clinical practice in the management of acute ischemic stroke (Palabras claves:Autores:Bahit M.C., Berwanger O., Bettger J.P., Bueno P.R.T., Cavalcanti A.B., Damiani L.P., De Andrade Jesuíno I., De Salles A., Gorgulho A., Guimarães H.P., Lopes R.D., Machline-Carrion M.J., Málaga G., Martins S.O., Normilio-Silva K., Octavio Marques Pontes-Neto, Pacheco Da Silva B.G., Peterson E.D., Rodrigues De Freitas G., Santos J.Y., Santucci E.V., Xian Y., Zétola V.H.F.Fuentes:scopusColchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
ArticleAbstract: Background: The large number of patients worldwide infected with the SARS-CoV-2 virus has overwhelmePalabras claves:Autores:Ali Z., Anand S.S., Avezum A.J., Bangdiwala S.I., Belley-Cote E.P., Berwanger O., Bosch J.J., Choudhri S., Dans A.L., Eikelboom J.W., Farkouh M.E., Felix Camilo, Harper W.L., Hassany M., Heenan L., Jolly S.S., Kontsevaya A., Loeb M., Lopes R.D., Pais P., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Sharma S.K., Tarhuni W.M., Wasserman S., Whitlock R.P., Xavier D., Xu L., Yusuf S., Yusufali A.M.Fuentes:googlescopus